Evofem Biosciences Announces Financial Results for the Second Quarter of 2023
SAN DIEGO, Aug. 14, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) today announced financial results for the second quarter and first half of 2023.
- SAN DIEGO, Aug. 14, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) today announced financial results for the second quarter and first half of 2023.
- "This marks the second consecutive quarter in which our net product sales surpassed our sales and marketing costs.
- "The reported net sales were lower than anticipated due to unexpected returns received in the second quarter of product with short-dated shelf life.
- For the three months ended June 30, 2023, net product sales were $2.5 million compared to $6.0 million in the prior year period.